SYNOPSYS, INC. | ||||||||
Unaudited Condensed Consolidated Balance Sheets (1) | ||||||||
(in thousands, except par value amounts) | ||||||||
| ||||||||
|
|
|
| April 30, 2022 |
| October 31, 2021 |
|
|
ASSETS: |
|
|
|
|
|
|
|
|
Current assets: |
|
|
|
|
|
|
|
|
Cash and cash equivalents |
|
|
| $ 1,573,620 |
| $ 1,432,840 |
|
|
Short-term investments |
|
|
| 146,901 |
| 147,949 |
|
|
Total cash, cash equivalents & short-term investments |
|
|
| $ 1,720,521 |
| $ 1,580,789 |
|
|
Accounts receivable, net |
|
|
| 722,992 |
| 568,501 |
|
|
Inventories |
|
|
| 213,532 |
| 229,023 |
|
|
Prepaid and other current assets |
|
|
| 417,201 |
| 430,028 |
|
|
Total current assets |
|
|
| 3,074,246 |
| 2,808,341 |
|
|
Property and equipment, net |
|
|
| 491,641 |
| 472,398 |
|
|
Operating lease right-of-use assets, net |
|
|
| 585,108 |
| 493,251 |
|
|
Goodwill |
|
|
| 3,616,133 |
| 3,575,785 |
|
|
Intangible assets, net |
|
|
| 333,321 |
| 279,132 |
|
|
Deferred income taxes |
|
|
| 605,785 |
| 612,655 |
|
|
Other long-term assets |
|
|
| 504,147 |
| 510,698 |
|
|
Total assets |
|
|
| $ 9,210,381 |
| $ 8,752,260 |
|
|
|
|
|
|
|
|
|
|
|
LIABILITIES, REDEEMABLE NON-CONTROLLING INTEREST AND STOCKHOLDERS' EQUITY: |
|
|
|
|
|
|
|
|
Current liabilities: |
|
|
|
|
|
|
|
|
Accounts payable and accrued liabilities |
|
|
| $ 612,221 |
| $ 741,191 |
|
|
Operating lease liabilities, current |
|
|
| 55,170 |
| 79,678 |
|
|
Deferred revenue |
|
|
| 1,795,267 |
| 1,517,623 |
|
|
Short-term debt |
|
|
| - |
| 74,992 |
|
|
Total current liabilities |
|
|
| 2,462,658 |
| 2,413,484 |
|
|
Operating lease liabilities, non-current |
|
|
| 601,317 |
| 487,003 |
|
|
Long-term deferred revenue |
|
|
| 165,911 |
| 136,303 |
|
|
Long-term debt |
|
|
| 23,775 |
| 25,094 |
|
|
Other long-term liabilities |
|
|
| 345,774 |
| 391,433 |
|
|
Total liabilities |
|
|
| 3,599,435 |
| 3,453,317 |
|
|
Redeemable non-controlling interest |
|
|
| 43,516 |
| - |
|
|
Stockholders' equity: |
|
|
|
|
|
|
|
|
Preferred stock, $0.01 par value: 2,000 shares authorized; none outstanding |
| - |
| - |
|
| ||
Common stock, $0.01 par value: 400,000 shares authorized; 152,955 and |
|
|
|
|
|
| ||
153,062 shares outstanding, respectively |
|
|
| 1,530 |
| 1,531 |
|
|
Capital in excess of par value |
|
|
| 1,517,481 |
| 1,576,363 |
|
|
Retained earnings |
|
|
| 5,157,633 |
| 4,549,713 |
|
|
Treasury stock, at cost: 4,306 and 4,198 shares, respectively |
|
|
| (999,234) |
| (782,866) |
|
|
Accumulated other comprehensive income (loss) |
|
|
| (113,099) |
| (49,604) |
|
|
Total Synopsys stockholders' equity |
|
|
| 5,564,311 |
| 5,295,137 |
|
|
Non-controlling interest |
|
|
| 3,119 |
| 3,806 |
|
|
Total stockholders' equity |
|
|
| 5,567,430 |
| 5,298,943 |
|
|
Total liabilities, redeemable non-controlling interest and
|
|
|
| $ 9,210,381 |
| $ 8,752,260 |
|
|
|
|
|
|
|
|
|
|
|
(1) Synopsys' second quarter of fiscal year 2022 ended on April 30, 2022 and its fiscal year 2021 ended on October 30, 2021. For presentation purposes, we refer to the closest calendar month end. |
|
| ||||||
|
|